TOP STORIES

• BUSINESS Cancer Specialist BeiGene Set to Enter Japan Market as Early as This Year
  February 16, 2024

• BUSINESS GSK Japan Nets 11% Sales Rise in 2023, Sees 6% CAGR through 2026: President
  February 15, 2024

• REGULATORY Japan to Announce New Drug Prices on March 5
  February 15, 2024

• REGULATORY Chuikyo Issues 2024 Reform Recommendation; 1,000 Yen Premium Set for Inpatient Biosimilar Use
  February 14, 2024

• REGULATORY Japan Approves Jardiance for CKD, Label Expansion for Opdivo and More
  February 13, 2024

• BUSINESS Medac Poised to Cement Japan Foothold in RA, Eyes Rare Disease Launch Too: CEO
  February 9, 2024

• BUSINESS Mounjaro Logs 5.6 Billion Yen in Q3 YTD despite Curbed Shipments: Mitsubishi
  February 8, 2024

• REGULATORY Generic Panel to Issue Report in Spring-Summer to Drive Manufacturing Efficiency towards Stable Supplies: Official
  February 8, 2024

• REGULATORY Legal Changes on Horizon for GMP Inspection Authorities, Other Regulation Panel Topics?
  February 7, 2024

• BUSINESS 2,000 Patients Receiving Leqembi in US, 4 Times the Number on Wait List: Eisai
  February 7, 2024

• REGULATORY AMED Needs More Manpower to Fulfill Its Role as Funding Agency: President
  February 6, 2024

• BUSINESS Sumitomo to Reinforce Restructuring to Fight Deficit, First in North America: President
  February 6, 2024

• REGULATORY Truvada Clears Preliminary Review for PrEP Use, but Coverage Not Granted
  February 6, 2024

• REGULATORY Will Truvada Win Health Coverage as Japan’s First Drug for HIV Prevention?
  February 5, 2024

• BUSINESS Chugai’s 2023 Earnings Slip as Ronapreve Wanes, but Sales Still Top 1 Trillion Yen
  February 2, 2024

• REGULATORY Japan to Introduce Fee Premium for Inpatient Biosimilar Use, Covering 13 APIs
  February 1, 2024

• BUSINESS Sumitomo to Cut Med- to Long-Term Guidance amid Tepid Uptake of New Drivers
  February 1, 2024

• REGULATORY Japan to Revise Ad Guidelines to Address GLP-1 Use for Cosmetic Weight Loss
  January 31, 2024

• COMMENTARY Is Case of Leqembi a “Steppingstone” to New CEA Price Adjustment Rule? Pharma Industry on Guard
  January 30, 2024

• REGULATORY MHLW to Require Pharma to Disclose More Categories of Physician Payments under Clinical Trials Act
  January 30, 2024

ページ

• « 先頭
• ‹ Prev
• …
• 35
• 36
• 37
• 38
• 39
• 40
• 41
• 42
• 43
• …
• Next ›
• 最終 »